Recent Advances in Biomaterial‐Based High‐Throughput Platforms

High‐throughput systems allow screening and analysis of large number of samples simultaneously under same conditions. Over recent years, high‐throughput systems have found applications in fields other than drug discovery like bioprocess industries, pollutant detection, material microarrays, etc. With the introduction of materials in such HT platforms, the screening system has been enabled for solid phases apart from conventional solution phase. The use of biomaterials has further facilitated cell‐based assays in such platforms. Here, the authors have focused on the recent developments in biomaterial‐based platforms including the fabricationusing contact and non‐contact methods and utilization of such platforms for discovery of novel biomaterials exploiting interaction of biological entities with surface and bulk properties. Finally, the authors have elaborated on the application of the biomaterial‐based high‐throughput platforms in tissue engineering and regenerative medicine, cancer and stem cell studies. The studies show encouraging applications of biomaterial microarrays. However, success in clinical applicability still seems to be a far off task majorly due to absence of robust characterization and analysis techniques. Extensive focus is required for developing personalized medicine, analytical tools and storage/shelf‐life of cell laden microarrays.